Jianqi Lian

3.7k total citations
58 papers, 867 citations indexed

About

Jianqi Lian is a scholar working on Epidemiology, Infectious Diseases and Immunology. According to data from OpenAlex, Jianqi Lian has authored 58 papers receiving a total of 867 indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Epidemiology, 21 papers in Infectious Diseases and 19 papers in Immunology. Recurrent topics in Jianqi Lian's work include Hepatitis B Virus Studies (24 papers), Viral Infections and Vectors (14 papers) and Hepatitis C virus research (12 papers). Jianqi Lian is often cited by papers focused on Hepatitis B Virus Studies (24 papers), Viral Infections and Vectors (14 papers) and Hepatitis C virus research (12 papers). Jianqi Lian collaborates with scholars based in China, United States and India. Jianqi Lian's co-authors include Ye Zhang, Xue–Fan Bai, Chang–Xing Huang, Michael D. Robek, Pingzhong Wang, Carmen J. Booth, Jiuping Wang, Wen Kang, Yongtao Sun and Wenzhen Kang and has published in prestigious journals such as SHILAP Revista de lepidopterología, Gastroenterology and PLoS ONE.

In The Last Decade

Jianqi Lian

56 papers receiving 849 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jianqi Lian China 17 342 320 298 188 153 58 867
Hans Heiken Germany 15 374 1.1× 466 1.5× 189 0.6× 268 1.4× 142 0.9× 37 1.1k
Ichiro Misumi United States 15 170 0.5× 396 1.2× 218 0.7× 191 1.0× 168 1.1× 27 806
Katharina Esser‐Nobis Germany 12 334 1.0× 342 1.1× 258 0.9× 228 1.2× 298 1.9× 17 862
Iwona Mozer‐Lisewska Poland 16 281 0.8× 192 0.6× 210 0.7× 314 1.7× 89 0.6× 101 764
Chang–Xing Huang China 13 222 0.6× 246 0.8× 194 0.7× 112 0.6× 82 0.5× 37 585
Tobias Manigold Switzerland 14 242 0.7× 367 1.1× 189 0.6× 205 1.1× 212 1.4× 29 908
Norma Rallón Spain 22 620 1.8× 429 1.3× 402 1.3× 638 3.4× 134 0.9× 99 1.4k
Yufeng Yao China 17 318 0.9× 309 1.0× 182 0.6× 74 0.4× 274 1.8× 78 931
D. Torre Italy 15 326 1.0× 140 0.4× 191 0.6× 144 0.8× 100 0.7× 47 815

Countries citing papers authored by Jianqi Lian

Since Specialization
Citations

This map shows the geographic impact of Jianqi Lian's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jianqi Lian with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jianqi Lian more than expected).

Fields of papers citing papers by Jianqi Lian

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jianqi Lian. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jianqi Lian. The network helps show where Jianqi Lian may publish in the future.

Co-authorship network of co-authors of Jianqi Lian

This figure shows the co-authorship network connecting the top 25 collaborators of Jianqi Lian. A scholar is included among the top collaborators of Jianqi Lian based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jianqi Lian. Jianqi Lian is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Mengyuan, Hang Yuan, Xiaofei Yang, Yingfeng Lei, & Jianqi Lian. (2025). Glutamine-glutamate centered metabolism as the potential therapeutic target against Japanese encephalitis virus-induced encephalitis. Cell & Bioscience. 15(1). 6–6. 1 indexed citations
2.
3.
Jiang, Fan, Yinping Liu, Yong Xue, et al.. (2023). Developing a multiepitope vaccine for the prevention of SARS-CoV-2 and monkeypox virus co-infection: A reverse vaccinology analysis. International Immunopharmacology. 115. 109728–109728. 31 indexed citations
4.
5.
Jiang, Hong, Chang–Xing Huang, Fuchun Zhang, et al.. (2022). Expert Consensus on the Prevention and Treatment of Hemorrhagic Fever with Renal Syndrome. SHILAP Revista de lepidopterología. 2(4). 224–232. 11 indexed citations
6.
Zhou, Yun, Hong Du, Tao Wang, et al.. (2022). The Comparison of Inflammatory Cytokines (IL-6 and IL-18) and Immune Cells in Japanese Encephalitis Patients With Different Progression. Frontiers in Cellular and Infection Microbiology. 12. 826603–826603. 6 indexed citations
7.
He, Yu, Yonghong Guo, Chao Fan, et al.. (2017). Interferon-α-Enhanced CD100/Plexin-B1/B2 Interactions Promote Natural Killer Cell Functions in Patients with Chronic Hepatitis C Virus Infection. Frontiers in Immunology. 8. 1435–1435. 10 indexed citations
8.
Du, Hong, Haitao Yu, Jianqi Lian, et al.. (2015). HMGB‐1 as a Novel Predictor of Disease Severity and Prognosis in Patients with Hemorrhagic Fever with Renal Syndrome. Mediators of Inflammation. 2015(1). 696248–696248. 10 indexed citations
9.
Ma, Li, Yun Zhou, Yun Zhou, et al.. (2014). Role of A20 in interferon‐α‐mediated functional restoration of myeloid dendritic cells in patients with chronic hepatitis C. Immunology. 143(4). 670–678. 9 indexed citations
10.
Hao, Chun-Qiu, Yun Zhou, Yu He, et al.. (2014). Imbalance of regulatory T cells and T helper type 17 cells in patients with chronic hepatitis C. Immunology. 143(4). 531–538. 29 indexed citations
11.
He, Yu, Yonghong Guo, Yun Zhou, et al.. (2014). CD100 Up-Regulation Induced by Interferon-α on B Cells Is Related to Hepatitis C Virus Infection. PLoS ONE. 9(12). e113338–e113338. 8 indexed citations
12.
Hao, Chun-Qiu, Jiuping Wang, Wenzhen Kang, et al.. (2013). Kinetics of Th17 Cytokines During Telbivudine Therapy in Patients With Chronic Hepatitis B. Viral Immunology. 26(5). 336–342. 12 indexed citations
13.
Zhang, Ye, Haitao Yu, Ruilin Sun, et al.. (2012). Inhibition of Viral Replication Downregulates CD4 + CD25 high Regulatory T Cells and Programmed Death-Ligand 1 in Chronic Hepatitis B. Viral Immunology. 25(1). 21–28. 25 indexed citations
14.
Zhao, Jun, et al.. (2010). Changes in the profiles of bacteria causing spontaneous bacterial peritonitis: A recent twelve-year study. African Journal of Microbiology Research. 4(7). 527–533. 3 indexed citations
15.
Ma, Li, Xin Wei, Ye Zhang, et al.. (2009). Observation of chimeric hepatitis C virus In infected Huh7.5 cell through transmission electron microscopy. Zhonghua weishengwuxue he mianyixue zazhi. 29(6). 568–573. 1 indexed citations
16.
Wei, Xin, Jianqi Lian, Ye Zhang, et al.. (2009). Inhibition of Hepatitis C Virus Infection by Interferon-γ Through Downregulating Claudin-1. Journal of Interferon & Cytokine Research. 29(3). 171–178. 20 indexed citations
17.
Wang, Pingzhong, Chang–Xing Huang, Ye Zhang, et al.. (2009). Analysis of the Immune Response to Hantaan Virus Nucleocapsid Protein C-Terminal-Specific CD8 + T Cells in Patients with Hemorrhagic Fever with Renal Syndrome. Viral Immunology. 22(4). 253–260. 14 indexed citations
18.
Lian, Jianqi, Xiaoqin Wang, Ye Zhang, Chang–Xing Huang, & Xue–Fan Bai. (2009). Correlation of Circulating TLR2/4 Expression with CD3 + /4 + /8 + T Cells and Treg cells in HBV-Related Liver Cirrhosis. Viral Immunology. 22(5). 301–308. 18 indexed citations
19.
Zhang, Ye, Jianqi Lian, Chang–Xing Huang, et al.. (2009). Overexpression of Toll-like receptor 2/4 on monocytes modulates the activities of CD4+CD25+ regulatory T cells in chronic hepatitis B virus infection. Virology. 397(1). 34–42. 43 indexed citations
20.
Lian, Jianqi. (2000). Intracellular application of two unit ribozyme gene against hepatitis B virus. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hans Heiken Breakdown of academic impact, for papers by Ichiro Misumi Breakdown of academic impact, for papers by Katharina Esser‐Nobis Breakdown of academic impact, for papers by Iwona Mozer‐Lisewska Breakdown of academic impact, for papers by Chang–Xing Huang Breakdown of academic impact, for papers by Tobias Manigold Breakdown of academic impact, for papers by Norma Rallón Breakdown of academic impact, for papers by Yufeng Yao Breakdown of academic impact, for papers by D. Torre
Rankless by CCL
2026